A study found that in a syngeneic mouse model, sEVs carrying the surface membrane protein SIRPα were transported to tumor sites, disrupting the CD47-SIRPα interaction and increasing the ability of macrophages to engulf tumor cells. The gene discussed is SIRPA; the disease is neoplasm.